| MIRLET7A3 |
|
microRNA let-7a-3
|
|
|
0.751 |
0.269 |
| ALL1 |
|
Leukemia, acute lymphocytic, susceptibility to, 1
|
|
|
0.636 |
0.269 |
| SLU7 |
O95391
|
SLU7 homolog, splicing factor
|
Nucleic acid binding
|
1.6E-09 |
0.729 |
0.346 |
| TRIB2 |
Q92519
|
tribbles pseudokinase 2
|
Kinase
|
0.98 |
0.628 |
0.462 |
| TCL1A |
P56279
|
T cell leukemia/lymphoma 1A
|
|
5.7E-10 |
0.558 |
0.500 |
| MLLT11 |
Q13015
|
MLLT11 transcription factor 7 cofactor
|
|
0.53 |
0.633 |
0.500 |
| CHFR |
Q96EP1
|
checkpoint with forkhead and ring finger domains
|
Enzyme
|
7.9E-04 |
0.633 |
0.500 |
| TK1 |
P04183
|
thymidine kinase 1
|
Kinase
|
0.14 |
0.592 |
0.538 |
| CDC20 |
Q12834
|
cell division cycle 20
|
Enzyme modulator
|
3.0E-07 |
0.587 |
0.577 |
| JARID2 |
Q92833
|
jumonji and AT-rich interaction domain containing 2
|
Transcription factor
|
1.00 |
0.615 |
0.577 |
| PRAME |
P78395
|
preferentially expressed antigen in melanoma
|
|
2.4E-07 |
0.531 |
0.577 |
| SOX7 |
Q9BT81
|
SRY-box transcription factor 7
|
Transcription factor
|
3.5E-07 |
0.599 |
0.577 |
| MSI2 |
Q96DH6
|
musashi RNA binding protein 2
|
|
0.99 |
0.592 |
0.577 |
| AXL |
P30530
|
AXL receptor tyrosine kinase
|
Kinase
|
1.3E-02 |
0.489 |
0.615 |
| HIC1 |
Q14526
|
HIC ZBTB transcriptional repressor 1
|
Transcription factor
|
0.13 |
0.522 |
0.615 |
| SEMG1 |
P04279
|
semenogelin 1
|
|
0.36 |
0.628 |
0.615 |
| AKAP12 |
Q02952
|
A-kinase anchoring protein 12
|
|
3.6E-02 |
0.566 |
0.615 |
| BAAT |
Q14032
|
bile acid-CoA:amino acid N-acyltransferase
|
|
7.9E-08 |
0.578 |
0.654 |
| BNIP3L |
O60238
|
BCL2 interacting protein 3 like
|
|
0.15 |
0.636 |
0.654 |
| CHGB |
P05060
|
chromogranin B
|
|
2.4E-07 |
0.599 |
0.654 |
| COL4A2 |
P08572
|
collagen type IV alpha 2 chain
|
|
3.6E-15 |
0.563 |
0.654 |
| FLT3 |
P36888
|
fms related receptor tyrosine kinase 3
|
Kinase
|
0.61 |
0.462 |
0.654 |
| HOXA13 |
P31271
|
homeobox A13
|
|
0.96 |
0.552 |
0.654 |
| CD177 |
Q8N6Q3
|
CD177 molecule
|
|
|
0.595 |
0.654 |
| DERL1 |
Q9BUN8
|
derlin 1
|
Receptor
|
2.1E-04 |
0.576 |
0.654 |